Sporelin Pharmaceuticals Private Limited
About Sporelin Pharmaceuticals Private Limited
Data last updated:
Sporelin Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 12 May 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U51101MH2015PTC264410. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rustumrao Tulashiram Kolhal and Dasharath Baliram Korde.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at P No 284 Growth Centre W.M Nagari Cidco, Aurangabad, Maharashtra, India – 431136.
As per the financials filed for FY 2019, the company reported a revenue of ₹12.95 Lakh, a decline of 38% compared to the previous year. For the same year it recorded a net profit of ₹5.7 Lakh (net margin 44%) and EBITDA of ₹5.7 Lakh (EBITDA margin 44%). Revenue has grown at a compounded annual rate (CAGR) of 109% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sporelin Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressP No 284 Growth Centre W.M Nagari Cidco, Aurangabad, Maharashtra, India – 431136
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Sporelin Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sporelin Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Sporelin Pharmaceuticals Private Limited, buy the company report.
Financials of Sporelin Pharmaceuticals Private Limited
FY 2019 filings availableSporelin Pharmaceuticals Private Limited reported revenue of ₹12.95 Lakh (down 38% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue fell 38% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 109%. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹5.7 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5.7 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 44% | |||
| Net Profit Margin | 44% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sporelin Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sporelin Pharmaceuticals Private Limited
Sporelin Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rustumrao Tulashiram Kolhal | Director | 25 Nov 2022 | 3 Years 11 Months | Current |
| Dasharath Baliram Korde | Director | 15 Nov 2021 | 4 Years 11 Months | Current |
Peer comparison
Sporelin Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sporelin Pharmaceuticals Private Limitedthis company | ₹12.95 Lakh (FY 2019) | ₹5.7 Lakh | 44% | -38.0% | Aurangabad, Maharashtra, India | |
| MGD Pharmaceuticals Private Limited | ₹12.91 Lakh (FY 2024) | 690.0% | Thane, Maharashtra, India | |||
| Pinklap Pharmaceuticals Private Limited | ₹12.9 Lakh (FY 2020) | Badlapur, Thane, Maharashtra, India | ||||
| Sukem Pharmaceuticals Private Limited | ₹12.9 Lakh (FY 2025) | 7.0% | New Delhi, Delhi, India |
To see the full peer comparison of Sporelin Pharmaceuticals Private Limited, buy the company report.
Auditor
Sporelin Pharmaceuticals Private Limited is audited by BIPENDRAKANTILALKOTHARI for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BIPENDRAKANTILALKOTHARI | FY 2017 | 111529 |
Shareholding
The shareholding of Sporelin Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Sporelin Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Sporelin Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sporelin Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sporelin Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Sporelin Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sporelin Pharmaceuticals Private Limited has 5 board changes on record since 2021: 2 appointments and 3 cessations. The latest: Raju Yashwanta More ceased to be Director on 25 Nov 2022.
Frequently asked questions
Sporelin Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 12 May 2015 (11+ years old) and is registered under CIN U51101MH2015PTC264410.
Sporelin Pharmaceuticals has 2 current directors:
- Rustumrao Tulashiram Kolhal - Director
- Dasharath Baliram Korde - Director
The latest financial statements of Sporelin Pharmaceuticals on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2016 are in the company report.
No. Sporelin Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Sporelin Pharmaceuticals is U51101MH2015PTC264410. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sporelin Pharmaceuticals was incorporated on 12 May 2015, making it 11+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Sporelin Pharmaceuticals by revenue are MGD Pharmaceuticals Private Limited, Pinklap Pharmaceuticals Private Limited, Sukem Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Raju Yashwanta More ceased to be Director on 25 Nov 2022. Rustumrao Tulashiram Kolhal was appointed as Director on 25 Nov 2022. Dasharath Baliram Korde was appointed as Director on 15 Nov 2021. Sporelin Pharmaceuticals has 5 board changes on record in total.
The registered office of Sporelin Pharmaceuticals is at P No 284 Growth Centre W.M Nagari Cidco, Aurangabad, Maharashtra, India – 431136.
Sporelin Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
The compliance status of Sporelin Pharmaceuticals is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.